011504 DAPSONE 8.5% / NIACINAMIDE 4%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2020-07-02
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:33:03
Label at a glance#
Product011504 DAPSONE 8.5% / NIACINAMIDE 4%
Active ingredientDAPSONE, NIACINAMIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions
Active, inactive
NDC 72934-1212-2 011504 DAPSONE 8.5% / NIACINAMIDE 4% gel 30 gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DAPSONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4ae3f83f-9ccb-db71-5718-0b1e959868df | Product name | 5 | 20260113 |
| 5ae2790a-f798-4a69-8811-64a4723c389a | Product name | 5 | 20250325 |
| b8929bfc-0002-d39a-046d-72ddf714efbe | Product name | 6 | 20190618 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-1212-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-9be0-a426-e053-dadaa90af4c2 | 011504 DAPSONE 8.5% / NIACINAMIDE 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-1212-2 | 011504 DAPSONE 8.5% / NIACINAMIDE 4% | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-1212 | 011504 DAPSONE 8.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20200703_a97aeb21-4efc-3d91-e053-2995a90a2298.zip |
Products#
Every source-derived product name is available through these pages.
- 011504 DAPSONE 8.5% / NIACINAMIDE 4%
- DAPSONE
- NIACINAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-1212 | 72934-1212-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DAPSONE | 8W5C518302 | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a97aeb21-4efd-3d91-e053-2995a90a2298 | a97aeb21-4efc-3d91-e053-2995a90a2298 | 2020-07-02 | Adverse reactions | a97aeb21-4efd-3d91-e053-2995a90a2298 a97aeb21-4efc-3d91-e053-2995a90a2298 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


